Zeng Li Yang
Chief Executive Officer presso AUTOBIO DIAGNOSTICS CO., LTD.
Profilo
Attualmente, Zeng Li Yang ricopre la posizione di direttore generale e direttore di Autobio Diagnostics Co. È anche nel consiglio di amministrazione di Beijing Bio-Top Biotechnology Co.
Posizioni attive di Zeng Li Yang
| Società | Posizione | Inizio |
|---|---|---|
| AUTOBIO DIAGNOSTICS CO., LTD. | Chief Executive Officer | 29/10/2018 |
Autobio Biochemistry Co., Ltd.
 Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AUTOBIO DIAGNOSTICS CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Autobio Biochemistry Co., Ltd.
Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Zeng Li Yang
